35.10
price up icon2.12%   0.73
 
loading
Guardant Health Inc stock is traded at $35.10, with a volume of 994.07K. It is up +2.12% in the last 24 hours and up +71.14% over the past month. Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
See More
Previous Close:
$34.37
Open:
$35.05
24h Volume:
994.07K
Relative Volume:
0.48
Market Cap:
$4.32B
Revenue:
$643.81M
Net Income/Loss:
$-490.76M
P/E Ratio:
-8.6453
EPS:
-4.06
Net Cash Flow:
$-299.27M
1W Performance:
+14.41%
1M Performance:
+71.14%
6M Performance:
+37.54%
1Y Performance:
+43.85%
1-Day Range:
Value
$34.53
$35.56
1-Week Range:
Value
$30.30
$36.02
52-Week Range:
Value
$15.81
$37.04

Guardant Health Inc Stock (GH) Company Profile

Name
Name
Guardant Health Inc
Name
Phone
855-698-8887
Name
Address
3100 HANOVER STREET, PALO ALTO
Name
Employee
1,779
Name
Twitter
@guardanthealth
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
GH's Discussions on Twitter

Compare GH with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
GH
Guardant Health Inc
35.10 4.32B 643.81M -490.76M -299.27M -4.06
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
521.66 199.82B 42.37B 6.14B 7.78B 15.26
Diagnostics & Research icon
DHR
Danaher Corp
238.83 173.66B 23.74B 3.89B 4.98B 7.93
Diagnostics & Research icon
A
Agilent Technologies Inc
138.14 38.64B 6.51B 1.29B 1.37B 3.82
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
201.43 36.52B 15.32B 1.41B 1.96B 5.95
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
421.76 34.55B 3.84B 866.24M 792.60M 9.80

Guardant Health Inc Stock (GH) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-28-24 Upgrade Guggenheim Neutral → Buy
Jun-03-24 Resumed Jefferies Buy
Apr-24-24 Resumed Craig Hallum Buy
Dec-14-23 Initiated Guggenheim Neutral
Dec-13-23 Initiated Wolfe Research Peer Perform
Nov-13-23 Upgrade Raymond James Mkt Perform → Outperform
Sep-28-23 Initiated Bernstein Outperform
Sep-27-23 Upgrade Piper Sandler Neutral → Overweight
Jul-05-23 Resumed JP Morgan Overweight
May-26-23 Upgrade Citigroup Neutral → Buy
May-05-23 Initiated UBS Buy
Mar-09-23 Downgrade Citigroup Buy → Neutral
Jan-05-23 Initiated Scotiabank Sector Outperform
Nov-01-22 Downgrade Piper Sandler Overweight → Neutral
Oct-19-22 Initiated Craig Hallum Buy
Oct-06-22 Initiated Stephens Overweight
Aug-25-22 Initiated Credit Suisse Outperform
Jun-03-22 Initiated Piper Sandler Overweight
Apr-28-22 Resumed BTIG Research Buy
Feb-24-22 Reiterated Canaccord Genuity Buy
Feb-24-22 Reiterated Citigroup Buy
Feb-24-22 Reiterated Cowen Outperform
Feb-24-22 Reiterated Morgan Stanley Overweight
Feb-24-22 Reiterated SVB Leerink Outperform
Feb-24-22 Reiterated Stifel Buy
Feb-24-22 Reiterated Wells Fargo Overweight
Oct-15-21 Resumed Cowen Outperform
Jun-15-21 Initiated Raymond James Mkt Perform
Jun-03-21 Initiated Goldman Buy
May-25-21 Initiated Wells Fargo Overweight
Jan-11-21 Initiated Stifel Buy
Sep-09-20 Initiated Morgan Stanley Overweight
Jun-12-20 Initiated BTIG Research Buy
Feb-21-20 Initiated Guggenheim Buy
Jan-07-20 Initiated Citigroup Buy
Aug-07-19 Reiterated Canaccord Genuity Buy
Apr-16-19 Initiated Canaccord Genuity Buy
Apr-10-19 Upgrade BofA/Merrill Neutral → Buy
Feb-28-19 Reiterated BofA/Merrill Neutral
Oct-29-18 Initiated BofA/Merrill Neutral
Oct-29-18 Initiated JP Morgan Overweight
Oct-29-18 Initiated William Blair Outperform
View All

Guardant Health Inc Stock (GH) Latest News

pulisher
Nov 27, 2024

KAS Team Wins $292.5 Million In Jury Trial of Guardant Health v. Natera - Morningstar

Nov 27, 2024
pulisher
Nov 27, 2024

Advantage Alpha Capital Partners LP Buys New Position in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat

Nov 27, 2024
pulisher
Nov 26, 2024

Personalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.

Nov 26, 2024
pulisher
Nov 25, 2024

Guardant Health, Inc. (GH) Stock Price, News, Quote & History - Yahoo Finance

Nov 25, 2024
pulisher
Nov 25, 2024

Jury Awards Guardant Health $292.5M in False-Advertising Lawsuit Against Natera - MarketWatch

Nov 25, 2024
pulisher
Nov 25, 2024

Guardant says jury unanimously found in favor of company in Natera suit - TipRanks

Nov 25, 2024
pulisher
Nov 25, 2024

Guardant Health gains amid $292.5M verdict against Natera over false advertising claims - MSN

Nov 25, 2024
pulisher
Nov 25, 2024

Guardant Health gains amid $292.5M verdict against Natera over false advertising claims (update) - MSN

Nov 25, 2024
pulisher
Nov 25, 2024

Guardant Health Wins Historic $292.5M False Advertising Verdict Against Natera | NTRA Stock News - StockTitan

Nov 25, 2024
pulisher
Nov 25, 2024

Natera Plans Appeal After Guardant Health Lawsuit Verdict, Defends Signatera Test Leadership | NTRA Stock News - StockTitan

Nov 25, 2024
pulisher
Nov 25, 2024

BREAKING: Jury Finds Natera Owes Guardant $292.5M In False Ad Suit - Law360

Nov 25, 2024
pulisher
Nov 24, 2024

Landscape Capital Management L.L.C. Acquires Shares of 31,448 Guardant Health, Inc. (NASDAQ:GH) - MarketBeat

Nov 24, 2024
pulisher
Nov 23, 2024

Guardant Health, Inc. (GH): Among the Most Promising Cancer Stocks According to Hedge Funds - Insider Monkey

Nov 23, 2024
pulisher
Nov 23, 2024

(GH) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Nov 23, 2024
pulisher
Nov 22, 2024

Natera's Conduct 'Despicable,' Guardant Says As Trial Wraps - Law360

Nov 22, 2024
pulisher
Nov 22, 2024

Guardant Health (GH) Set To Dominate The Growing Liquid Biopsy Market - Insider Monkey

Nov 22, 2024
pulisher
Nov 21, 2024

Guardant Health, Inc. (NASDAQ:GH) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 21, 2024
pulisher
Nov 20, 2024

GH (Guardant Health) Operating Cash Flow per Share : $-2.10 (TTM As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

Guardant Health Stock Sees RS Rating Jump To 83 - Yahoo! Voices

Nov 20, 2024
pulisher
Nov 20, 2024

Guardant Health: Focused On Future Growth, Hold - Seeking Alpha

Nov 20, 2024
pulisher
Nov 20, 2024

GH (Guardant Health) Free Cash Flow per Share : $-2.26 (TTM As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

Guardant Health, Inc. (NASDAQ:GH) Q3 2024 Earnings Call Transcript - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Guardant Health CIO Kumud Kalia sells $204,722 in stock - Investing.com India

Nov 19, 2024
pulisher
Nov 19, 2024

Guardant Health Inc (GH) Shares Up 5.46% on Nov 19 - GuruFocus.com

Nov 19, 2024
pulisher
Nov 17, 2024

Sumitomo Mitsui Trust Group Inc. Grows Stake in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat

Nov 17, 2024
pulisher
Nov 16, 2024

Guardant Health (FRA:5GH) Total Inventories : €65.1 Mil (As of Sep. 2024) - GuruFocus.com

Nov 16, 2024
pulisher
Nov 15, 2024

Natera Exec Calls Guardant's Cancer Test Claims 'Dangerous' - Law360

Nov 15, 2024
pulisher
Nov 15, 2024

Insider Selling: Director Meghan Joyce Sells Shares of Guardant Health Inc (GH) - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Guardant Health director Meghan Joyce sells $86,595 in stock - Investing.com

Nov 14, 2024
pulisher
Nov 13, 2024

CADIAN CAPITAL MANAGEMENT, LP's Strategic Acquisition in Guardan - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Guardant Atty Accuses Natera CEO Of Dishonesty At Trial - Law360

Nov 13, 2024
pulisher
Nov 13, 2024

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Nov 13, 2024
pulisher
Nov 13, 2024

Guardant Health, Inc. (NASDAQ:GH) Shares Sold by Baillie Gifford & Co. - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

ESR1 Mutated Metastatic Breast Cancer Diagnostics Market - openPR

Nov 13, 2024
pulisher
Nov 13, 2024

Guardant Health Inc (GH) Stock Price Up 6.63% on Nov 13 - GuruFocus.com

Nov 13, 2024
pulisher
Nov 12, 2024

Guardant CEO Says Rival's False Ads Hurt 'Beautiful Baby' - Law360

Nov 12, 2024
pulisher
Nov 09, 2024

Multi-cancer Early Detection Market Next Big Thing| Major Giants Exact Sciences, AnchorDx, Guardant Health - openPR

Nov 09, 2024
pulisher
Nov 08, 2024

Wellington Management Group LLP Bolsters Stake in Guardant Healt - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

Market Participants Recognise Guardant Health, Inc.'s (NASDAQ:GH) Revenues Pushing Shares 36% Higher - Simply Wall St

Nov 08, 2024
pulisher
Nov 08, 2024

Guardant Health, Inc. (NASDAQ:GH) Shares Bought by ARK Investment Management LLC - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Guardant Health Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

Why Guardant Health Stock Blasted 13% Higher on Thursday - MSN

Nov 08, 2024
pulisher
Nov 07, 2024

Ex-Natera VP Defends Ad Campaign Against Rival Guardant - Law360

Nov 07, 2024
pulisher
Nov 07, 2024

Guardant Health (GH) Stock Surges on Strong Q3 Earnings - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Guardant Health Pops 13% On An 'Impressive' Beat Following Exact Sciences' Flop - Yahoo! Voices

Nov 07, 2024
pulisher
Nov 07, 2024

Leerink stays bullish on Guardant Health stock, citing robust growth prospects - Investing.com Canada

Nov 07, 2024
pulisher
Nov 07, 2024

JPMorgan Chase & Co. Raises Guardant Health (NASDAQ:GH) Price Target to $50.00 - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Guardant Health (NASDAQ:GH) Shares Gap Up Following Analyst Upgrade - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Guardant Health (NASDAQ:GH) Price Target Raised to $36.00 at The Goldman Sachs Group - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Guardant Health Inc (GH) Trading 13.31% Higher on Nov 7 - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Guardant Health Inc (GH) Q3 2024 Earnings Call Highlights: Recor - GuruFocus.com

Nov 07, 2024

Guardant Health Inc Stock (GH) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research LH
$242.15
price up icon 1.43%
$168.45
price up icon 0.08%
$144.36
price up icon 0.99%
diagnostics_research WAT
$386.57
price down icon 0.41%
diagnostics_research MTD
$1,243.40
price up icon 0.90%
$421.76
price up icon 1.06%
Cap:     |  Volume (24h):